No Data
CEL-SCI Announces Proposed Public Offering of Common Stock
Express News | Amex Halt Add Info Lst 0.840000
CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study
Express News | Watching CEL-SCI; Zacks Small-Cap Research Gives Stock $7 Price Valuation
Express News | CEL-SCI Corp: On November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer
CEL-SCI, FDA Agree on Patient Selection Approach for Multikine Study
No Data
Benjamin’s : You missed the
run at noon 
.